## Abstract Imatinib is standard first‐line treatment for patients with advanced gastrointestinal stromal tumor (GIST). Initial responses are not always accompanied by reductions in tumor size; consequently, other parameters should be considered in response assessments. Conventional size‐based crit
Gastrointestinal stromal tumor in a patient surviving osteosarcoma
✍ Scribed by Gallegos-Castorena, Sergio ;Martínez-Avalos, Armando ;Francisco Ortiz de la O, Edgar ;Sadowinsky-Pine, Stasnislaw ;Lezama del Valle, Pablo ;Guerrero-Avendaño, Guadalupe
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 108 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## BACKGROUND. Telomerase activity has been observed in 80 -90% of carcinomas derived from various organs. However, to the authors' knowledge this report is the first assessment of telomerase activity in gastrointestinal stromal tumors (GISTs). ## METHODS. Telomerase activity was analyzed by th
## Abstract Gastrointestinal stromal tumors (GIST) have been suggested to be the most common neurofibromatosis 1‐associated gastrointestinal tumors. This case report describes and compares US and CT findings of both abdominal neurofibromas and a gastrointestinal stromal tumor. On US, the GIST appea